These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 14667889

  • 1. Long-term low-dose dehydroepiandrosterone oral supplementation in early and late postmenopausal women modulates endocrine parameters and synthesis of neuroactive steroids.
    Genazzani AD, Stomati M, Bernardi F, Pieri M, Rovati L, Genazzani AR.
    Fertil Steril; 2003 Dec; 80(6):1495-501. PubMed ID: 14667889
    [Abstract] [Full Text] [Related]

  • 2. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
    Stomati M, Monteleone P, Casarosa E, Quirici B, Puccetti S, Bernardi F, Genazzani AD, Rovati L, Luisi M, Genazzani AR.
    Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
    [Abstract] [Full Text] [Related]

  • 3. Oral dehydroepiandrosterone supplementation modulates spontaneous and growth hormone-releasing hormone-induced growth hormone and insulin-like growth factor-1 secretion in early and late postmenopausal women.
    Genazzani AD, Stomati M, Strucchi C, Puccetti S, Luisi S, Genazzani AR.
    Fertil Steril; 2001 Aug; 76(2):241-8. PubMed ID: 11476767
    [Abstract] [Full Text] [Related]

  • 4. Long-term low-dose dehydroepiandrosterone replacement therapy in aging males with partial androgen deficiency.
    Genazzani AR, Inglese S, Lombardi I, Pieri M, Bernardi F, Genazzani AD, Rovati L, Luisi M.
    Aging Male; 2004 Jun; 7(2):133-43. PubMed ID: 15672938
    [Abstract] [Full Text] [Related]

  • 5. Endocrine, neuroendocrine and behavioral effects of oral dehydroepiandrosterone sulfate supplementation in postmenopausal women.
    Stomati M, Rubino S, Spinetti A, Parrini D, Luisi S, Casarosa E, Petraglia F, Genazzani AR.
    Gynecol Endocrinol; 1999 Feb; 13(1):15-25. PubMed ID: 10368794
    [Abstract] [Full Text] [Related]

  • 6. Variability of serum estrogens among postmenopausal women treated with the same transdermal estrogen therapy and the effect on androgens and sex hormone binding globulin.
    Kraemer GR, Kraemer RR, Ogden BW, Kilpatrick RE, Gimpel TL, Castracane VD.
    Fertil Steril; 2003 Mar; 79(3):534-42. PubMed ID: 12620436
    [Abstract] [Full Text] [Related]

  • 7. Long-term low-dose oral administration of dehydroepiandrosterone modulates adrenal response to adrenocorticotropic hormone in early and late postmenopausal women.
    Genazzani AR, Pluchino N, Begliuomini S, Stomati M, Bernardi F, Pieri M, Casarosa E, Palumbo M, Genazzani AD, Luisi M.
    Gynecol Endocrinol; 2006 Nov; 22(11):627-35. PubMed ID: 17145649
    [Abstract] [Full Text] [Related]

  • 8. The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women.
    Morales AJ, Haubrich RH, Hwang JY, Asakura H, Yen SS.
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):421-32. PubMed ID: 9876338
    [Abstract] [Full Text] [Related]

  • 9. Effect of postmenopausal estrogen replacement on circulating androgens.
    Casson PR, Elkind-Hirsch KE, Buster JE, Hornsby PJ, Carson SA, Snabes MC.
    Obstet Gynecol; 1997 Dec; 90(6):995-8. PubMed ID: 9397118
    [Abstract] [Full Text] [Related]

  • 10. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology.
    Labrie F, Bélanger A, Cusan L, Candas B.
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2403-9. PubMed ID: 9253308
    [Abstract] [Full Text] [Related]

  • 11. [Study on relationship between endogenous androgens and insulin resistance at the different stages of postmenopause].
    Cao YK, Zhang SF, Zou SE, Xia X, Xu LN.
    Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):740-4. PubMed ID: 24406129
    [Abstract] [Full Text] [Related]

  • 12. Neuroendocrine effect of a short-term treatment with DHEA in postmenopausal women.
    Rubino S, Stomati M, Bersi C, Casarosa E, Luisi M, Petraglia F, Genazzani AR.
    Maturitas; 1998 Jan 12; 28(3):251-7. PubMed ID: 9571601
    [Abstract] [Full Text] [Related]

  • 13. Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy.
    Dören M, Rübig A, Coelingh Bennink HJ, Holzgreve W.
    Fertil Steril; 2001 Mar 12; 75(3):554-9. PubMed ID: 11239541
    [Abstract] [Full Text] [Related]

  • 14. Effects of estrogen replacement therapy on dehydroepiandrosterone, dehydroepiandrosterone sulfate, and cortisol responses to exercise in postmenopausal women.
    Johnson LG, Kraemer RR, Haltom R, Kraemer GR, Gaines HE, Castracane VD.
    Fertil Steril; 1997 Nov 12; 68(5):836-43. PubMed ID: 9389812
    [Abstract] [Full Text] [Related]

  • 15. One-year therapy with 10mg/day DHEA alone or in combination with HRT in postmenopausal women: effects on hormonal milieu.
    Pluchino N, Ninni F, Stomati M, Freschi L, Casarosa E, Valentino V, Luisi S, Genazzani AD, Potì E, Genazzani AR.
    Maturitas; 2008 Apr 20; 59(4):293-303. PubMed ID: 18394829
    [Abstract] [Full Text] [Related]

  • 16. Transdermal 17 beta-estradiol combined with oral progestogen increases plasma levels of insulin-like growth factor-I in postmenopausal women.
    Slowinska-Srzednicka J, Zgliczynski S, Jeske W, Stopinska-Gluszak U, Srzednicki M, Brzezinska A, Zgliczynski W, Sadowski Z.
    J Endocrinol Invest; 1992 Apr 20; 15(7):533-8. PubMed ID: 1280287
    [Abstract] [Full Text] [Related]

  • 17. Correlation between the Aging Males' Symptoms Scale and sex steroids, gonadotropins, dehydroepiandrosterone sulfate, and growth hormone levels in ambulatory men.
    Miwa Y, Kaneda T, Yokoyama O.
    J Sex Med; 2006 Jul 20; 3(4):723-726. PubMed ID: 16839329
    [Abstract] [Full Text] [Related]

  • 18. Reduced androgen levels in adult turner syndrome: influence of female sex steroids and growth hormone status.
    Gravholt CH, Svenstrup B, Bennett P, Sandahl Christiansen J.
    Clin Endocrinol (Oxf); 1999 Jun 20; 50(6):791-800. PubMed ID: 10468952
    [Abstract] [Full Text] [Related]

  • 19. Cross-sectional association of endogenous steroid hormone, sex hormone-binding globulin, and precursor steroid levels with hemostatic factor levels in postmenopausal women.
    Harrington LB, Marck BT, Wiggins KL, McKnight B, Heckbert SR, Woods NF, LaCroix AZ, Blondon M, Psaty BM, Rosendaal FR, Matsumoto AM, Smith NL.
    J Thromb Haemost; 2017 Jan 20; 15(1):80-90. PubMed ID: 27797446
    [Abstract] [Full Text] [Related]

  • 20. Pituitary function and DHEA-S in male acne and DHEA-S, prolactin and cortisol before and after oral contraceptive treatment in female acne.
    Palatsi R, Reinilä M, Kivinén S.
    Acta Derm Venereol; 1986 Jan 20; 66(3):225-30. PubMed ID: 2426899
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.